Coronavirus Disease COVID 19

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is caused by one virus, called severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.

Overview

Feature Articles

Latest Coronavirus Disease COVID 19 News and Research

Supercarriers: Just 2% of SARS-CoV-2 positive people carry 90% of the virus

Supercarriers: Just 2% of SARS-CoV-2 positive people carry 90% of the virus

A look at how coronavirus disease (COVID-19) affects Parkinson's

A look at how coronavirus disease (COVID-19) affects Parkinson's

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity

A magnetofluidic platform for SARS-CoV-2 variant and respiratory pathogen detection

A magnetofluidic platform for SARS-CoV-2 variant and respiratory pathogen detection

Three-way strategy employed by SARS-CoV-2 during infection

Three-way strategy employed by SARS-CoV-2 during infection

Dominance of South African SARS-CoV-2 variant in the US is unlikely but possible

Dominance of South African SARS-CoV-2 variant in the US is unlikely but possible

Antibodies generated by malaria cross-react with SARS-CoV-2

Antibodies generated by malaria cross-react with SARS-CoV-2

Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study

Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study

UCLA Health wins $750,000 grant to scale COVID-19 innovations and support health equity

UCLA Health wins $750,000 grant to scale COVID-19 innovations and support health equity

Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study

Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

Another pandemic ‘to do’ on the list for schools: Contact tracing

Another pandemic ‘to do’ on the list for schools: Contact tracing

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

No placental damage observed in case study of pregnant women with mRNA COVID-19 vaccinations

No placental damage observed in case study of pregnant women with mRNA COVID-19 vaccinations

Black fungus complicates India's COVID pandemic

Black fungus complicates India's COVID pandemic

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Inexpensive test for rapid detection of COVID-19 with 90% accuracy

Inexpensive test for rapid detection of COVID-19 with 90% accuracy